|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Steatorrhea | |||||
| 2 | More general conditions related to this trial | ||||
| Digestive System Diseases | |||||
| Gastrointestinal Diseases | |||||
| Intestinal Diseases | |||||
| Malabsorption Syndromes | |||||
| Metabolic Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| Creon 25000 | |||||
| Placebo | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Pancreatin | |||||
| Pancrelipase | |||||
| 5 | More general drug interventions related to this trial | ||||
| Gastrointestinal Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Solvay Pharmaceuticals | |||||